IRMD

IRADIMED CORP Form 8-K Summary

Business Context and Reporting Period

This Form 8-K reports the final results of the 2019 Annual Meeting of Stockholders held on June 14, 2019. IRADIMED Corporation is an emerging growth company incorporated in Delaware, with its common stock trading on the NASDAQ Capital Market under the symbol IRMD.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses exclusively on corporate governance voting results.

Material Changes

There are no material financial changes reported in this filing. The document details the ratification of the independent auditor and the election of directors.

Guidance, Outlook, and Management Commentary

The filing contains no guidance, outlook, or management commentary regarding future financial performance. It confirms the ratification of RSM US LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2019.

Investor Verification Checklist

• Verify the election of Roger Susi, Monty Allen, Anthony Vuoto, and James Hawkins to the Board of Directors.
• Confirm the ratification of RSM US LLP as the independent auditor for the 2019 fiscal year.
• Note the significant number of broker non-votes (2,750,531) recorded for all director elections.
• Review the 2019 Annual Report (Form 10-K) for detailed financial performance data not included in this 8-K.

Voting Results Summary